1. Introduction {#sec0005}
===============

Coronaviruses are large, enveloped, single-stranded RNA viruses that cause respiratory and/or enteric disease in mammals and birds. In dogs, three coronaviruses have been described so far. Canine coronavirus (CCoV) type I (CCoV-I) and type II (CCoV-II) are enteric viruses belonging to the old antigenic group 1 ([@bib0020], [@bib0025]), recently classified as a new genus *Alphacoronavirus* ([@bib0015]). According to the new taxonomy, CCoVs are included in the same species, *Alphacoronavirus-1*, as feline and some swine coronaviruses ([@bib0015]). Canine respiratory coronavirus (CRCoV), first reported in UK by [@bib0105], is a *Betacoronavirus* ([@bib0015]) causing respiratory distress especially when associated to other pathogens ([@bib0005], [@bib0060]). CCoV-I and CCoV-II are widely distributed in Europe ([@bib0085], [@bib0090]) and are usually responsible for mild to moderate gastroenteritis in pups, although death can occur as a consequence of simultaneous infections by both genotypes ([@bib0130], [@bib0040]) or by other pathogens ([@bib0030], [@bib0045], [@bib0050], [@bib0055]). CCoV infection is usually restricted to the gastroenteric tract, and associated with anorexia, diarrhoea and vomiting ([@bib0140]). However, in 2005 a fatal outbreak of CCoV-II infection was reported in pups housed in a pet shop of Apulia region, Italy ([@bib0010]). Coronavirus RNA (strain CB/05) was detected in the internal organs of the pups, presenting severe gross lesions, while other canine pathogens were not detected. Experimental infections of seronegative dogs reproduced the disease with the severity varying with the age of the infected animals ([@bib0010], [@bib0070]). In addition, strain CB/05 was able to infect dogs with immunity to enteric CCoVs, causing both enteric and systemic signs, chiefly lymphopenia ([@bib0080]). Subsequent experiments revealed that lymphopenia is the most prominent finding after infection by pantropic CCoV, with a marked long-lasting depletion of the circulating CD4+ T lymphocytes ([@bib0120]). Upon genomic analysis, strain CB/05 showed a high degree of homology to reference CCoV strains ([@bib0065]). Unique point mutations were present at the N-terminus of the spike (S) protein, including an Asp/His to Asn change at position 125. In addition, a unique 38-nucleotide deletion was mapped within ORF3b.

In the present paper, the isolation of a novel pantropic CCoV strain is reported. The strain was characterised molecularly by sequencing the 3′ end of the RNA genome. Also, the virus was characterised biologically by experimental infection of seronegative dogs.

2. Methods {#sec0010}
==========

2.1. Clinical case {#sec0015}
------------------

In October 2007, a 60-day-old miniature pinscher died from systemic disease characterised by fever (39.5--40 °C), leucopenia (4.7 × 10^9^  cells/L, reference range 6--17 × 10^9^  cells/L), mainly lymphopenia (0.5 × 10^9^  cells/L, reference range 1.0--4.8 × 10^9^  cells/L), lethargy, anorexia, vomiting and haemorrhagic diarrhoea. One week before death, the pup had been bought in a pet shop in Apulia region, Italy, and ten days before had been administered a single dose of a vaccine containing canine parvovirus, canine distemper virus, canine adenovirus type 2, *Leptospira canicola* and *Leptospira icterohaemorrhagie*. Supportive therapy with antibiotics (amoxicillin/clavulanic acid) and fluids (lactated Ringer\'s solution) was not effective and the clinical conditions continued to deteriorate until the pup died.

Necropsy revealed gross lesions in the alimentary tract (haemorrhagic enteritis), tonsils (necrotic areas), lungs (fibrinous pneumonia), liver (enlargement and areas of necrosis), spleen (enlargement) and kidneys (degeneration of the cortex). At post-mortem examination, samples were collected from brain, lungs, spleen, liver, mesenteric lymph nodes, kidneys, and intestinal content for molecular and virological investigations. Histopathology was not carried out as all tissue samples were frozen at −20 °C.

2.2. Molecular and virological investigations {#sec0020}
---------------------------------------------

After DNA and RNA purifications using commercial kits, intestinal contents and tissue samples collected from the dead dog were screened for major canine viral pathogens, as previously described ([@bib0065]). Characterisation of the CCoV genotypes was carried out by a type-specific real-time RT-PCR assays ([@bib0040]).

The sequence of the 3′ end of the genome of the pantropic CCoV strain detected in the lungs was determined as previously described ([@bib0065]) and registered in GenBank ([http://www.ncbi.nlm.nih.gov](http://www.ncbi.nlm.nih.gov/)) under accession number [GU146061](ncbi-n:GU146061). Phylogenetic and molecular evolutionary analyses were conducted using Mega4.0 ([@bib0135]). Phylogenetic trees, based on the spike (S) and membrane (M)-nucleocapsid (N) proteins of strain 450/07 were elaborated using both parsimony and neighbour-joining methods, supplying a statistical support with bootstrapping over 1000 replicates.

The lung of the pup was homogenised (10%, w/v) in D-MEM with antibiotics (penicillin 5000 IU/mL, streptomycin 2500 μg/mL, amphotericin B 10 μg/mL), and inoculated into canine fibroma (A-72) cells. Infected cells were monitored daily for the occurrence of cytopathic effect (CPE) and, after 5 days of incubation, they *Alphacoronaviurs-1* antigen was detected by an immunofluorescence (IF) assay using a monoclonal antibody targeting the N protein (courtesy of Dr. Gill Chappuis, Merial, France).

2.3. Experimental infection of dogs {#sec0025}
-----------------------------------

Nine 10-to-11-week-old CCoV-seronegative beagles from the same litter were used for this challenge study after a 7-days acclimatisation period (authorisation no. 57/2006-C from Italian Ministry of Health). Each dog was individually housed for the administration of the challenge and to monitor clinical signs. All animals were weighed on study days −3, −1, 3, and 5. On study day 0, the six dogs in treatment group T02 were challenged with a total volume of 4 mL (3.0 mL orally and 1.0 mL intra-nasally; 0.5 mL per nostril) containing 10^5^  TCID~50~/mL of strain 450/07 (3rd passage on A-72 cells). Three control dogs in group T01 received the same volume of a cryolysate of uninfected A-72 cells by the same route of administration. All dogs were monitored daily for clinical signs by the attending veterinarian starting on day −1 (before challenge) and for as long as the animals remained in the study. The general health of each animal was assessed using the scoring system described in [Table 1](#tbl0005){ref-type="table"} . EDTA-blood samples were collected from the jugular vein on study days −3, 0 (pre-challenge), 3, and 5 (day of necropsy) for complete and differential blood cell counts. Rectal temperatures (°C) were measured at arrival, on study day −3, and then daily until study day 5. Nasal and rectal swabs were collected on study days −3, −1, 3, and 5.Table 1Scoring system for general health observations during the challenge trial.ParameterResultScoreGeneral appearanceNormal0Depressed/lethargic2Difficulties in breathing3Death20DehydrationNone (\<4%): not detectable0Mild (4--5%): subtle loss of skin elasticity1Moderate (6--8%): definite delay in return of skin to normal position; eyes possibly sunken in orbits; slightly prolonged capillary refill time; possibly dry mucous membranes2Severe (10--15%): tented skin standing in place; prolonged capillary refill time; eyes sunken in orbits; dry mucous membranes possible signs of shock (increased heart rate, weak pulses); death imminent3DiarrhoeaNone0Soft1Liquid2Bloody3Rectal temperature37.0--39.4 °C0≥39.5 °C2\<37.0 °C3Body weightWeight loss2No weight loss1Weight gain0

Five days post-challenge, all dogs were sedated by intravenous administration of 10 mg/kg of body weight of Zoletil^®^ 100 (Virbac S.r.l., Italy) and euthanised by intravenous administration of 0.5 mL/kg of body weight of Tanax^®^ (Intervet Italia, Italy). During necropsy, samples for histopathology and IHC were collected from small intestine, mesenteric, intermandibular and popliteal lymph nodes, lung, liver, spleen, and kidney, and stored in formalin. Fresh tissue samples were also collected in D-MEM and RNA Later Solution (QIAGEN S.p.A.) for viral isolation and real-time RT-PCR assays, respectively, and kept at −70 °C until used. Formalin-embedded samples were cut in 3-μm sections and stained with haematoxylin--eosin (H&E) for histological examination or treated with an anti-*Alphacoronavirus-1* monoclonal antibody binding to the N protein for immunohistochemistry (IHC) ([@bib0010]). EDTA-blood samples and faecal swabs collected *intra-vitam*, as well as tissue samples collected at necropsy examination, were tested for CCoV by virus isolation on A-72 cells and/or by real-time RT-PCR ([@bib0035]).

3. Results {#sec0030}
==========

3.1. Identification of a CB/05-like strain in internal organs of the dead dog {#sec0035}
-----------------------------------------------------------------------------

The intestinal content and tissue samples of the dead dog (450/07) tested negative for all viral pathogens with the eccepition of CCoV. By real-time RT-PCR ([@bib0035]), the highest viral RNA load (5.81 × 10^6^  RNA copies/μL of template) was found in the lung sample, but the virus was also detected in the intestinal content (8.57 × 10^5^  RNA copies/μL of template), mesenteric lymph nodes (2.31 × 10^5^  RNA copies/μL of template), spleen (1.78 × 10^4^  RNA copies/μL), liver (3.43 × 10^3^  RNA copies/μL), kidney (7.09 × 10^3^  RNA copies/μL). Only traces of CCoV RNA (4.36 × 10^1^  RNA copies/μL) were detected in the brain sample. The virus (strain 450/07) was characterised as CCoV-II by means of the genotype-specific TaqMan assays ([@bib0040]) and as CCoV-IIa by means of subgenotype-specific RT-PCR assays ([@bib0085]).

The lung sample was used for virus isolation as it contained the highest viral load. Viral growth was observed by the first passage, as CPE appeared in the infected cells and CCoV antigen was detected by IF staining. Three serial passages were carried out in order to obtain a stock virus (10^5^  TCID~50~/mL) of strain 450/07 for the challenge experiment. The stock virus was tested for the presence of other canine viral pathogens and for sterility from aerobe and anaerobe bacteria, mycoplasmas and mycetes and no contaminant agent was detected.

The 3′ end of the genome of strain 450/07 was amplified from the lung material through amplification of seven overlapping fragments. The obtained sequence was 8618 nt long and contained the full length of ORFs 2, 3a, 3b, 3c, 4, 5, 6, 7a and 7b. The S protein (ORF2 product) was 1454 aa in length and it was highly related (99.5% aa identity) to the prototype pantropic strain CB/05. A high degree of genetic relatedness was found also in the other structural proteins, including the envelope (E, 82 aa, 100% aa identity), membrane (M, 262 aa, 99.2% identity) and nucleocapsid (N, 382 aa, 99.7% identity) proteins, encoded by ORFs 4, 5, and 6, respectively. The products of ORF 3a (71 aa), 3b (22 aa), 7a (101 aa) and 7b (213 aa) were intact with respect to the prototype strain CB/05. ORF3b contained the same 38-nt deletion as strain CB/05, but an additional 164-nt deletion was present in ORF3c. This deletion altered the frame shift, introducing an early stop codon at nt 4824 and affecting the correct synthesis of the ORF3c product.

Upon phylogenetic analysis, strain 450/07 clustered with strain CB/05 in the S ([Fig. 1](#fig0005){ref-type="fig"} ) and M/N protein sequences. Genetic relatedness with the recombinant CCoV/transmissible gastroenteritis virus strains (CCoV-IIb) ([@bib0075], [@bib0095]) was also evident in the M/N sequences (data not shown).Fig. 1Neighbour-joining tree based on the spike protein of members of genus *Alphacoronavirus*. For phylogenetic tree construction, the following CoV strains were used (GenBank accession numbers are reported in parentheses): porcine transmissible gastroenteritis virus (TGEV) Purdue ([NC_002306](ncbi-n:NC_002306)), TS ([DQ201447](ncbi-n:DQ201447)), 96-1933 ([AF104420](ncbi-n:AF104420)); porcine respiratory coronavirus (PRCoV) RM4 ([Z24675](ncbi-n:Z24675)), 86-137004 ([X60089](ncbi-n:X60089)); CCoV-IIa CB/05 ([DQ112226](ncbi-n:DQ112226)), Insavc-1 ([D13096](ncbi-n:D13096)), BGF10 ([AY342160](ncbi-n:AY342160)); CCoV-IIb 341/05 ([EU856361](ncbi-n:EU856361)), 174/06 ([EU856362](ncbi-n:EU856362)), 430/07 ([EU924790](ncbi-n:EU924790)), 118/08 ([EU924791](ncbi-n:EU924791)); CCoV-I Elmo/02 ([AY307020](ncbi-n:AY307020)), 23/03 ([AY307021](ncbi-n:AY307021)); feline coronavirus (FCoV) type I Black ([EU186072](ncbi-n:EU186072)), KU-1 ([D32044](ncbi-n:D32044)), UCD-1 ([AB088222](ncbi-n:AB088222)); FCoV-II 79-1146 ([NC_007025](ncbi-n:NC_007025)), 79-1183 ([X80799](ncbi-n:X80799)); HCoV-229E ([NC_002645](ncbi-n:NC_002645)), PEDV-CV777 ([NC_003436](ncbi-n:NC_003436)), HCoV-NL63 ([NC_005831](ncbi-n:NC_005831)). The tree is rooted on the *Betacoronavirus* canine respiratory coronavirus (CRCoV) 240/05 ([EU999954](ncbi-n:EU999954)). A statistical support was provided by bootstrapping over 1000 replicates. The scale bars indicate the estimated numbers of amino acid substitutions per site.

3.2. Clinical, post-mortem, histopathological and virological findings in experimentally infected dogs {#sec0040}
------------------------------------------------------------------------------------------------------

All six dogs in T02 and one of the three control dogs in T01 lost weight on day 3 after challenge compared to their (baseline) weight on day −1. Only one dog from T02 group had fever on day 4, but three more dogs in T02 showed a numerical increase in their rectal temperature within the normal range after challenge. This change in range was not observed in T01 control dogs. Two dogs in group T02 were found depressed or lethargic on days 3 and 4 after challenge and two dogs of the same group were mildly to severely dehydrated on days 3 and 4 after challenge. Soft faeces or diarrhoea were observed in four T02 dogs on days 3 and 4 after challenge. All six dogs in T02 had lymphadenomegalia on days 3, 4 or 5 in one of the dogs, on days 4 and 5 in two dogs and on day 5 in the other three dogs. One T02 dog had also nasal secretion on days 0, 1 and 4 post challenge and another challenged dog had decreased capillar refill and pale mucosa on day 5. Based on the scoring system reported in [Table 1](#tbl0005){ref-type="table"}, two of the three control pups had a clinical score of zero because they did not show any clinical signs. One of the T01 dogs lost weight on days 3 and 5 after challenge but did not show any other clinical sign. This pup had therefore a score of 4, with its group showing a mean score of 1.3. However, all six pups in T02 group showed a variety of clinical sings, which lasted between 1 and 3 days and therefore their scores ranged from 2 to 19 (mean 5.7).

Day −3 and day 0 lymphocyte and WBC counts per μL were averaged and were used as baseline levels to compare to the day 3 post-challenge levels. Lymphocyte counts decreased ≥30% in five dogs in T02, but less than 30% in the rest of dogs in T02 and T01. WBC counts decreased ≥30% in four of six dogs in T02, but less than ≥30% in the dogs left in T02 and in all the control dogs. The reduction in the lymphocyte counts was particularly dramatic for one T02 dog (75% with respect to the baseline values), that was the one that started showing clinical signs earlier and also showed the most severe clinical signs.

At necropsy, controls did not show any remarkable lesion, whereas four infected pups displayed mild to severe enteritis in one or more intestinal segments and five-presented enlargement of the mesenteric lymph nodes, that were congested and with scattered haemorrhages. Splenomegaly and involvement of popliteal and/or intermandibular lymph nodes were observed in one and two T02 pups, respectively. Lung congestion and haemorrhages on the thymus were detected only in one infected pup, whereas in four pups of group T02 abundant abdominal fluid was present.

H&E staining of intestinal sections from all infected pups showed diffuse lymphocytic and plasmacellular infiltration of the lamina propria with fusion of the duodenal villi and focal ectasia of the cryptae containing desquamated epithelial cells ([Fig. 2](#fig0010){ref-type="fig"}a). A diffuse lymphocytic depletion was evident in the mesenteric lymph nodes and/or spleen of these animals, with two pups displaying the same histologic changes also in the popliteal lymph nodes. Lung sections from one pup displayed marked leucocyte infiltration of alveolar walls, capillary congestion, multifocal hyperplasia of myocytes, and focal hyperplasia of the bronchial and bronchiolar epithelia; rare macrophages, erythrocytes and desquamated epithelial cells were present in the alveolar lumen ([Fig. 2](#fig0010){ref-type="fig"}b). Liver and kidney displayed some histopathological changes only in three and two pups, respectively, that consisted of fatty degeneration of hepatocytes and multifocal hyperaemia and ectasia of the renal cortex. By IHC, *Alphacoronavirus*-*1* N antigen was found to be widespread in the apical cells of the intestinal villi ([Fig. 2](#fig0010){ref-type="fig"}c) and mesenteric lymph nodes of five T02 pups, with positive cells being also detected in the lungs, spleen and popliteal lymph nodes ([Fig. 2](#fig0010){ref-type="fig"}d) of some pups. The liver and lung tissues of all pups tested IHC negative for coronaviral antigen. No remarkable histopathological changes neither IHC detection of coronaviral antigen were evident in T01 animals.Fig. 2Histopathological (a, b) and immunohistochemical (c, d) findings in pups experimentally infected with strain 450/07. (a) Jejunum of dog 9319: fusion and desquamation of intestinal villi and inflammatory cell infiltration in the lamina propria (H&E, 10×). (b) Lung of dog 9314: diffuse leucocyte infiltration of alveolar walls and epithelial desquamation (H&E, 10×). (c) Ileum of dog 9319: *Alphacoronavirus-1* antigen (brown stained) in epithelial cells (IHC with monoclonal antibody, 10×). (d) Popliteal lymph node of dog 9322: *Alphacoronavirus-1* antigen (brown stained) in lymphocytic cells (IHC with monoclonal antibody, 20×).

By real-time RT-PCR ([@bib0035]), three T02 pups were excreting virus on days 3 and/or 5 in their faeces, with titres ranging from 2.75 × 10^3^ to 1.07 × 10^7^  CCoV RNA copies per μL of template, and the viral RNA was detected in only one day 5 blood sample of a pup in T02 (titre of 5.73 × 10^1^  RNA copies per μL). As expected on the basis of the viral loads, CCoV was only isolated from a day 3 rectal swab from a pup in T02 group. Several tissues collected from five infected pups tested positive by real-time RT-PCR, with the highest titres being detected in the lymphoid tissues. CCoV was isolated from mesenteric lymph nodes in three dogs, from duodenum and jejunum in one dog and from ileum in two dogs from T02. Neither nasal swabs from T02 dogs nor any samples from T01 dogs tested positive to CCoV by real-time RT-PCR or virus isolation.

4. Discussion {#sec0045}
=============

In the present paper, we report the isolation of a novel pantropic CCoV strain from the lungs of a pup that died after systemic disease. The virus was characterised at the genetic level, displaying a close relatedness (more than 99% aa identity) to the prototype strain CB/05 in all the analysed proteins. Like strain CB/05, strain 450/07 displayed the unique mutation Asn-125 in the S protein, and the 38-nt deletion in ORF3b. These genetic signatures are not shared by all pantropic CCoV strains (Decaro et al., manuscript in preparation). An additional 164-deletion, affecting the protein frame shift, was mapped in ORF3c. Coronavirus accessory protein genes are believed to be dispensable for replication in vitro, but they are strictly maintained during infection of the natural hosts ([@bib0115]). In both the pantropic CCoV strains CB/05 and 450/07, the accessory protein 3b was 49 aa shorter than expected. In strain 450/07 the ORF3c product was likely not expressed due to the presence of an early stop codon in the 5′ end of the gene. Similar deletions in the accessory protein genes of feline coronavirus have been suggested to play a role in the enhanced virulence showed by the hypervirulent biotype feline infectious peritonitis virus ([@bib0110]). Enterotropic CCoV-II strains genetically related to CB/05 have been detected in recent years, but none of them displayed deletions in the accessory protein genes ([@bib0065]). Thus, strain 450/07 may have originated from the prototype virus CB/05 through an additional 164-nt deletion in ORF3c.

At the biological level, the isolates CB/05 and 450/07 were both able to infect pups and to spread to their internal organs, causing systemic disease and lymphopenia, although the severity of clinical signs and involvement of lymphoid tissues seemed to be more pronounced in CB/05 infected dogs. These apparent variations could be accounted for by differences in the breed and age of the infected dogs, in the dose and cell passage of the viruses used for the challenge and in the clinical score adopted to evaluate the induced disease. Variations in virulence have been observed in different challenge experiments using the same batch of CB/05 isolate ([@bib0070], [@bib0120]). A comprehensive study using simultaneously both viruses would help evaluate more precisely if the two strains differ in their pathogenic potential.

The isolation of a new pantropic CCoV strain from a dead pup suggests that this variant is circulating in dogs, as described in recent investigations ([@bib0125], [@bib0145]), stressing the need to develop homologous vaccines on the basis of the poor cross-protection induced by enteric CCoV ([@bib0080]).
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